These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 18313561)
21. Meta-analysis of individual patient data versus aggregate data from longitudinal clinical trials. Jones AP; Riley RD; Williamson PR; Whitehead A Clin Trials; 2009 Feb; 6(1):16-27. PubMed ID: 19254930 [TBL] [Abstract][Full Text] [Related]
22. Why add anything to nothing? The arcsine difference as a measure of treatment effect in meta-analysis with zero cells. Rücker G; Schwarzer G; Carpenter J; Olkin I Stat Med; 2009 Feb; 28(5):721-38. PubMed ID: 19072749 [TBL] [Abstract][Full Text] [Related]
24. Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses. Brok J; Thorlund K; Gluud C; Wetterslev J J Clin Epidemiol; 2008 Aug; 61(8):763-9. PubMed ID: 18411040 [TBL] [Abstract][Full Text] [Related]
25. Meta-analysis and meta-analytic monitoring of clinical trials. Feinstein AR Stat Med; 1996 Jun; 15(12):1273-80; discussion 1281-3. PubMed ID: 8817801 [TBL] [Abstract][Full Text] [Related]
26. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis. Heinz J; Kropf S; Luley C; Dierkes J Am J Kidney Dis; 2009 Sep; 54(3):478-89. PubMed ID: 19359080 [TBL] [Abstract][Full Text] [Related]
27. Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials. Daemen J; Boersma E; Flather M; Booth J; Stables R; Rodriguez A; Rodriguez-Granillo G; Hueb WA; Lemos PA; Serruys PW Circulation; 2008 Sep; 118(11):1146-54. PubMed ID: 18725490 [TBL] [Abstract][Full Text] [Related]
28. The conditional relative odds ratio provided less biased results for comparing diagnostic test accuracy in meta-analyses. Suzuki S; Moro-oka T; Choudhry NK J Clin Epidemiol; 2004 May; 57(5):461-9. PubMed ID: 15196616 [TBL] [Abstract][Full Text] [Related]
29. Practical and updated guidelines on performing meta-analyses of non-randomized studies in interventional cardiology. Navarese EP; Koziński M; Pafundi T; Andreotti F; Buffon A; Servi SD; Kubica J Cardiol J; 2011; 18(1):3-7. PubMed ID: 21305479 [TBL] [Abstract][Full Text] [Related]
30. Analysis of randomized controlled trials on the effect of magnitude of heart rate reduction on clinical outcomes in patients with systolic chronic heart failure receiving beta-blockers. Flannery G; Gehrig-Mills R; Billah B; Krum H Am J Cardiol; 2008 Mar; 101(6):865-9. PubMed ID: 18328855 [TBL] [Abstract][Full Text] [Related]
31. One relative risk versus two odds ratios: implications for meta-analyses involving paired and unpaired binary data. Zou GY Clin Trials; 2007; 4(1):25-31. PubMed ID: 17327243 [TBL] [Abstract][Full Text] [Related]
32. The questionable association of vitamin E supplementation and mortality--inconsistent results of different meta-analytic approaches. Gerss J; Köpcke W Cell Mol Biol (Noisy-le-grand); 2009 Feb; 55 Suppl():OL1111-20. PubMed ID: 19267994 [TBL] [Abstract][Full Text] [Related]
33. Prevention of sudden cardiac death with omega-3 fatty acids in patients with coronary heart disease: a meta-analysis of randomized controlled trials. Zhao YT; Chen Q; Sun YX; Li XB; Zhang P; Xu Y; Guo JH Ann Med; 2009; 41(4):301-10. PubMed ID: 19148838 [TBL] [Abstract][Full Text] [Related]
34. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 6. Systematic reviews and meta-analyses of observational studies. Manchikanti L; Datta S; Smith HS; Hirsch JA Pain Physician; 2009; 12(5):819-50. PubMed ID: 19787009 [TBL] [Abstract][Full Text] [Related]
35. Meta-analysis of heterogeneous clinical trials: an empirical example. Doi SA; Barendregt JJ; Mozurkewich EL Contemp Clin Trials; 2011 Mar; 32(2):288-98. PubMed ID: 21147265 [TBL] [Abstract][Full Text] [Related]
36. The safety of anti-tumour necrosis factor treatments in rheumatoid arthritis: meta and exposure-adjusted pooled analyses of serious adverse events. Leombruno JP; Einarson TR; Keystone EC Ann Rheum Dis; 2009 Jul; 68(7):1136-45. PubMed ID: 18753157 [TBL] [Abstract][Full Text] [Related]
37. Primary prevention of sudden cardiac death using implantable cardioverter defibrillators. Ding L; Hua W; Niu H; Chen K; Zhang S Europace; 2008 Sep; 10(9):1034-41. PubMed ID: 18559335 [TBL] [Abstract][Full Text] [Related]
38. Pioglitazone and cardiovascular risk. A comprehensive meta-analysis of randomized clinical trials. Mannucci E; Monami M; Lamanna C; Gensini GF; Marchionni N Diabetes Obes Metab; 2008 Dec; 10(12):1221-38. PubMed ID: 18505403 [TBL] [Abstract][Full Text] [Related]
39. Publication bias was not a good reason to discourage trials with low power. Borm GF; den Heijer M; Zielhuis GA J Clin Epidemiol; 2009 Jan; 62(1):47.e1-10. PubMed ID: 18620841 [TBL] [Abstract][Full Text] [Related]
40. Optimizing the use of patient data to improve outcomes for patients: narcotics for chronic noncancer pain. Busse JW; Guyatt GH Expert Rev Pharmacoecon Outcomes Res; 2009 Apr; 9(2):171-9. PubMed ID: 19402805 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]